F. Shieh

发表

Urine as a non-invasive alternative to blood for germline and somatic mutation detection in hepatocellular carcinoma

J. Hamilton, T. Gade, S. Jin, 2021, medRxiv.

Analytic performance studies and clinical reproducibility of a real-time PCR assay for the detection of epidermal growth factor receptor gene mutations in formalin-fixed paraffin-embedded tissue specimens of non-small cell lung cancer

K. Bloom, W. Maltzman, S. Anderson, 2013, BMC Cancer.

Clinical Validation of a PCR Assay for the Detection of EGFR Mutations in Non–Small-Cell Lung Cancer: Retrospective Testing of Specimens from the EURTAC Trial

B. Klughammer, M. Taron, S. Y. Cajal, 2014, PloS one.

Comparison of molecular testing methods for the detection of EGFR mutations in formalin-fixed paraffin-embedded tissue specimens of non-small cell lung cancer

F. López-Ríos, D. Gonzalez de Castro, R. Current, 2013, Journal of Clinical Pathology.

A comparison of three methods for detecting KRAS mutations in formalin-fixed colorectal cancer specimens

F. López-Ríos, D. Gonzalez de Castro, V. Brophy, 2012, British Journal of Cancer.

Comparison of Testing Methods for the Detection of BRAF V600E Mutations in Malignant Melanoma: Pre-Approval Validation Study of the Companion Diagnostic Test for Vemurafenib

F. López-Ríos, R. Langland, B. Angulo, 2013, PloS one.

The challenges of comparing a clinically validated test to other methods.

L. Kristensen, L. Hansen, P. Guldberg, 2013, The Journal of molecular diagnostics : JMD.

PP 28 Analytical performance and workflow comparison study of three methods for detecting KRAS mutations in formalin-fixed paraffin-embedded tissue (FFPET) specimens of colorectal cancer (CRC)

F. López-Ríos, V. Brophy, B. Angulo, 2011 .

Comparison of Molecular Testing Methods for Detecting BRAF V600 Mutations in Melanoma Specimens with Challenging Attributes

J. Longshore, J. Palma, G. Hillman, 2015 .